InvestorsHub Logo

DewDiligence

10/04/16 7:35 PM

#2482 RE: Stockyang #2481

The cash flow will be significantly reduced if a generic version of 40mg Copaxone enters the US market in early 2017 (#msg-124820193, #msg-125465255).